Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of gevokizumab in reducing the risk of
recurrent uveitic disease in subjects with non-infectious uveitis whose disease is currently
controlled with systemic treatment.